Pharma News, 2022

The FDA has granted a fast track designation to belzupacap sarotalocan (AU-011) for the treatment of patients with non–muscle invasive bladder cancer (NMIBC), representing the first virus-like dr...

Researchers from the University of Colorado School of Medicine analyzed drugs that could block the effect of the apolipoprotein E4 protein (APOE4), which is a risk factor gene for Alzheimer’s.&nb...

The FDA has lifted the clinical hold it placed on Vertex Pharmaceuticals’ phase 1/2 clinical trial of VX-880, an investigational treatment for patients with type 1 diabetes. ...

An international team of researchers experimenting with the function of the endocannabinoid system have shown how it can be manipulated to combat obesity with the help of a synthetic peptide. ...

A new systematic review has found repurposing some drugs currently used for ADHD and depression could offer small improvements to cognitive symptoms associated with Alzheimer’s disease.  ...

Rochester biologists used population genomics to study a selfish ‘supergene’ that skews genetic inheritance.

Some patients with COVID-19 will be able to get easier access to Pfizer’s oral antiviral therapy Paxlovid, after the FDA ruled that pharmacists would be able to prescribe the drug. ...

The rumour that Merck & Co is preparing to make a sizeable offer to buy cancer specialist Seagen won’t go away.

The U.S. Food and Drug Administration’s accelerated approval process has faced intense scrutiny over the past several months, with concerns ranging from a failure of drugs to live up to early cli...

The FDA has accepted Roche’s Biologics License Application (BLA) for Lunsumio (mosunetuzumab) and has granted the drug a priority review for treatment of adult patients with relapsed or refractor...

The FDA has started an accelerated review of Eisai and Biogen’s a new amyloid-targeting antibody lecanemab for Alzheimer’s disease, with a 6 January deadline that keep them ahead of closest ri...

The Interdisciplinary Association for Psychedelic Research reports that ecstasy (3,4-methyl​enedioxy​methamphetamine, MDMA) will be used for patients suffering from post-traumatic stress diso...